IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H).
暂无分享,去创建一个
M. Ban | S. Sawcer | A. Compston | A. Coles | C. Phuah | Joanne L. Jones | A. Cox | S. Thompson | A. Walton | Jacqueline Shawcross
[1] B. Müller-Myhsok,et al. Novel Genetic Risk Markers for Ulcerative Colitis in the IL2/IL21 Region Are in Epistasis With IL23R and Suggest a Common Genetic Background for Ulcerative Colitis and Celiac Disease , 2009, The American Journal of Gastroenterology.
[2] K. Selmaj,et al. Alemtuzumab vs. interferon beta-1a in early multiple sclerosis. , 2008, The New England journal of medicine.
[3] David E. Anderson,et al. IL-21 and TGF-β are required for differentiation of human TH17 cells , 2008, Nature.
[4] Hanne F. Harbo,et al. Refining genetic associations in multiple sclerosis , 2008, The Lancet Neurology.
[5] L. Walker,et al. Release from Regulatory T Cell-Mediated Suppression during the Onset of Tissue-Specific Autoimmunity Is Associated with Elevated IL-211 , 2008, The Journal of Immunology.
[6] J. Fechner,et al. CD4+CD25+FOXP3+ Regulatory T Cells Increase De Novo in Kidney Transplant Patients After Immunodepletion with Campath‐1H , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[7] Scott F. Saccone,et al. A Genome-Wide Association Study of Psoriasis and Psoriatic Arthritis Identifies New Disease Loci , 2008, PLoS genetics.
[8] S. Coons,et al. IL‐21 Modulates CD4+ CD25+ Regulatory T‐Cell Homeostasis in Experimental Autoimmune Encephalomyelitis , 2007, Scandinavian journal of immunology.
[9] B. Franke,et al. Novel association in chromosome 4q27 region with rheumatoid arthritis and confirmation of type 1 diabetes point to a general risk locus for autoimmune diseases. , 2007, American journal of human genetics.
[10] P. Lipsky,et al. Essential Role of IL-21 in B Cell Activation, Expansion, and Plasma Cell Generation during CD4+ T Cell-B Cell Collaboration1 , 2007, The Journal of Immunology.
[11] Yan Feng,et al. Critical regulation of CD4+ T cell survival and autoimmunity by β-arrestin 1 , 2007, Nature Immunology.
[12] P. Deloukas,et al. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21 , 2007, Nature Genetics.
[13] Simon C. Potter,et al. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.
[14] A. Tyndall,et al. Autoimmunity following haematopoietic stem-cell transplantation. , 2007, Best practice & research. Clinical haematology.
[15] Stephan Beck,et al. A second major histocompatibility complex susceptibility locus for multiple sclerosis , 2007, Annals of neurology.
[16] T. Macdonald,et al. IL-21 Counteracts the Regulatory T Cell-Mediated Suppression of Human CD4+ T Lymphocytes1 , 2007, The Journal of Immunology.
[17] Yan Feng,et al. Critical regulation of CD4+ T cell survival and autoimmunity by beta-arrestin 1. , 2007, Nature immunology.
[18] M. Segni,et al. Impaired caspase-3 expression by peripheral T cells in chronic autoimmune thyroiditis and in autoimmune polyendocrine syndrome-2. , 2006, The Journal of clinical endocrinology and metabolism.
[19] T. Fry,et al. Autoimmunity during lymphopenia: a two-hit model. , 2006, Clinical immunology.
[20] N. Wulffraat,et al. Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network. , 2006, Blood.
[21] P. Lipsky,et al. IL-21 Induces Differentiation of Human Naive and Memory B Cells into Antibody-Secreting Plasma Cells1 , 2005, The Journal of Immunology.
[22] Amanda L. Cox,et al. Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis , 2005, European journal of immunology.
[23] J. Berzofsky,et al. Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells , 2005, Nature Medicine.
[24] C. Lacey,et al. Characteristics of Autoimmune Thyroid Disease Occurring as a Late Complication of Immune Reconstitution in Patients With Advanced Human Immunodeficiency Virus (HIV) Disease , 2005, Medicine.
[25] H. Waldmann,et al. The window of therapeutic opportunity in multiple sclerosis , 2005, Journal of Neurology.
[26] F. Dotta,et al. Defective lymphocyte caspase-3 expression in type 1 diabetes mellitus. , 2005, European journal of endocrinology.
[27] N. Sarvetnick,et al. Homeostatic Expansion of T Cells during Immune Insufficiency Generates Autoimmunity , 2004, Cell.
[28] Jianzhu Chen,et al. Competition for self-peptide-MHC complexes and cytokines between naive and memory CD8+ T cells expressing the same or different T cell receptors. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[29] J. Markmann,et al. Homeostatic proliferation is a barrier to transplantation tolerance , 2004, Nature Medicine.
[30] B. Stockinger,et al. Involvement of Avidity for Major Histocompatibility Complex in Homeostasis of Naive and Memory T Cells , 2003, The Journal of experimental medicine.
[31] Y. Shoenfeld,et al. HIV and autoimmunity. , 2002, Autoimmunity reviews.
[32] Ethan M. Shevach,et al. Cutting Edge: Depletion of CD4+CD25+ Regulatory T Cells Is Necessary, But Not Sufficient, for Induction of Organ-Specific Autoimmune Disease , 2002, The Journal of Immunology.
[33] Jianzhu Chen,et al. Dependence of lymphopenia-induced T cell proliferation on the abundance of peptide/ MHC epitopes and strength of their interaction with T cell receptors. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[34] A. B. Lyons,et al. Flow cytometric analysis of cell division history using dilution of carboxyfluorescein diacetate succinimidyl ester, a stably integrated fluorescent probe. , 2001, Methods in cell biology.
[35] M. Kazatchkine,et al. Sequential occurrence of thyroid autoantibodies and Graves' disease after immune restoration in severely immunocompromised human immunodeficiency virus-1-infected patients. , 2000, The Journal of clinical endocrinology and metabolism.
[36] A. Chiocchetti,et al. Defective T cell Fas function in patients with multiple sclerosis , 2000, Neurology.
[37] Jianzhu Chen,et al. Homeostasis-Stimulated Proliferation Drives Naive T Cells to Differentiate Directly into Memory T Cells , 2000, The Journal of experimental medicine.
[38] L. Bogatzki,et al. Naive T Cells Transiently Acquire a Memory-like Phenotype during Homeostasis-Driven Proliferation , 2000, The Journal of experimental medicine.
[39] R. Ahmed,et al. Cutting Edge: Naive T Cells Masquerading as Memory Cells , 2000, The Journal of Immunology.
[40] A. Compston,et al. Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis , 1999, The Lancet.
[41] J. Bonnefoy,et al. Annexin V used for measuring apoptosis in the early events of cellular cytotoxicity. , 1999, Cytometry.
[42] Jingwu Z. Zhang,et al. Impaired apoptotic deletion of myelin basic protein‐reactive T cells in patients with multiple sclerosis , 1999, European Journal of Immunology.
[43] C. Caltagirone,et al. Impaired apoptosis in mitogen-stimulated lymphocytes of patients with multiple sclerosis. , 1999, Neuroreport.
[44] J. Ziegler,et al. Case report Acquired autoimmune thrombocytopenia post-bone marrow transplantation for severe combined immunodeficiency , 1998 .
[45] M. Toda,et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. , 1995, Journal of immunology.
[46] R. Coffman,et al. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. , 1993, International immunology.
[47] T. Dexter,et al. Effect of Campath-1H antibody on human hematopoietic progenitors in vitro. , 1993, Blood.
[48] P. Gleeson,et al. An autoimmune disease with multiple molecular targets abrogated by the transgenic expression of a single autoantigen in the thymus , 1993, The Journal of experimental medicine.